Letters to the Editor

Monitoring relapse in post-transplant acute myeloid leukemia requires integrated assessment, with flow cytometry showing the highest efficacy

Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Biostatistics,Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Biostatistics,Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Mar 26, 2026 https://doi.org/10.3324/haematol.2025.289192